Skip to: Content
Skip to: Section Navigation
Skip to: Site Navigation
Skip to: Search

Bracewell & Giuliani




ALM, 2008

Named as a Go-To Law Firm for Leading Technology Companies.   

Bracewell's Technology and Telecommunications Practice

Bracewell & Giuliani helps clients develop, protect and deploy innovative technologies in telecommunications, aerospace and defense, nanotechnology and other industries around the world. We provide strategic business, legal and governmental counsel to technology businesses at every stage of their business life — from initial creation and protection of ideas, through development of strong companies and establishment of market leadership, to mergers, acquisitions and other transactions. We help our clients:

  • Navigate governmental policies and regulations
  • License intellectual property
  • Raise capital from venture and angel investors
  • Identify and pursue government contracting opportunities
  • Secure public equity and debt financing
  • Merge, acquire and divest assets
  • Create joint ventures, alliances and partnerships
  • Manage employment and compensation issues.

Many of our lawyers have specific industry knowledge and business experience, having been trained in various technology-related and scientific disciplines. Working in multidisciplinary teams, we tap the experience of attorneys from the firm’s corporate, securities, tax, intellectual property, labor and employment, employee benefits and litigation departments.

Bracewell's environmental lawyers advise clients developing state-of-the art systems to produce power from wind, biofuels and other new sources of energy. Our clients are deeply involved in management of carbon-producing processes and in the development of technologies and techniques to control greenhouse gas emissions.

Bracewell represents emerging biosciences companies and institutions that develop medical imaging and pharmacology software, biochips, DNA-sequencing tools, wound-care supplies and drugs to treat Alzheimer's disease, AIDS and cancer. We also work with institutions to structure technology transfer agreements, and represent venture capitalists seeking investment opportunities in companies developing biosciences applications.



         
Related Information
People
News Releases
In the News
Legal Advisories
Publications and Speeches
Events
Notable